Aurobindo Pharma today said it has received a tentative approval from the US drug regulator for manufacturing and marketing of its Nevirapine tablets, used in the treatment of HIV infections.

Dishman Pharmaceuticals & Chemicals Ltd, a contract research & manufacturing services (CRAM) major, received the US Food and Drug Administration (USFDA) nod for producing Active Pharmaceutical Ingredients (API) at its Naroda facility here.

Drug firm Sun Pharmaceutical Industries on Wednesday said that its subsidiary, has received US Drug regulator approval for anti-hypertension drug.

US-based Zydus Pharmaceuticals, a subsidiary of Zydus Cadila, has received final approval from the US Food and Drug Administration (USFDA) to market Ramipril tablets, in the strengths of 1.25 mg, 2.5 mg, 5 mg and 10 mg.